KaloCyte, Inc.
PrivateLast Round
Seed
Feb 24, 2025
Total Funding Raised
$24.13M
Company Overview
KaloCyte, Inc. is a biotechnology company developing ErythroMer™, a dried, bio-inspired artificial red blood cell substitute for use when stored red blood cells are unavailable.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KaloCyte, Inc. Comparables
Compare KaloCyte, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VirTech Bio | 85% | |
| NanoBlood LLC | 85% | |
| Fluoro2 Therapeutics | 82% | |
KaloCyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 24, 2025 | ||||
| Grant | Feb 1, 2025 | ||||
| Grant | Jan 28, 2025 | ||||
| Grant | Apr 15, 2024 | ||||
| Grant | Aug 22, 2023 | ||||
Debt | Jul 17, 2023 |
Key People
Founding team and executive leadership
KaloCyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| TEDCO | Debt |
| BioGenerator Ventures | Angel |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Old Line Capital Partners | Convertible Debt |
| Ferocity Capital | Seed |
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2025
$2.6M round led by Ferocity Capital
- Jan 28, 2025
Selected to join collaboration with Johnson & Johnson and BARDA.
KaloCyte, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KaloCyte, Inc.'s valuation, stock price, and market status.